Basilea Pharmaceutica AG/Fr.BSLN
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Basilea Pharmaceutica AG
Ticker
Fr.BSLN
Sector
Primary listing
XSWX
Employees
180
Headquarters
Allschwil, Switzerland
Website
BSLN Metrics
BasicAdvanced
CHF 589M
8.86
CHF 5.40
0.61
-
Price and volume
Market cap
CHF 589M
Beta
0.61
52-week high
CHF 51.80
52-week low
CHF 44.75
Average daily volume
38K
Financial strength
Current ratio
6.323
Quick ratio
5.399
Long term debt to equity
91.826
Total debt to equity
93.825
Interest coverage (TTM)
12.25%
Profitability
EBITDA (TTM)
78.075
Gross margin (TTM)
46.39%
Net profit margin (TTM)
30.78%
Operating margin (TTM)
32.51%
Effective tax rate (TTM)
-0.54%
Revenue per employee (TTM)
CHF 1,310,000
Management effectiveness
Return on assets (TTM)
21.94%
Return on equity (TTM)
121.16%
Valuation
Price to earnings (TTM)
8.86
Price to revenue (TTM)
2.47
Price to book
5.71
Price to tangible book (TTM)
5.73
Price to free cash flow (TTM)
7.482
Free cash flow yield (TTM)
13.36%
Free cash flow per share (TTM)
6.395
Growth
Revenue change (TTM)
58.50%
Earnings per share change (TTM)
-10,076.87%
3-year revenue growth (CAGR)
15.94%
10-year revenue growth (CAGR)
17.51%
3-year earnings per share growth (CAGR)
323.60%
10-year earnings per share growth (CAGR)
0.51%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Basilea Pharmaceutica AG stock?
Basilea Pharmaceutica AG (BSLN) has a market cap of Fr.589M as of October 27, 2025.
What is the P/E ratio for Basilea Pharmaceutica AG stock?
The price to earnings (P/E) ratio for Basilea Pharmaceutica AG (BSLN) stock is 8.86 as of October 27, 2025.
Does Basilea Pharmaceutica AG stock pay dividends?
No, Basilea Pharmaceutica AG (BSLN) stock does not pay dividends to its shareholders as of October 27, 2025.
When is the next Basilea Pharmaceutica AG dividend payment date?
Basilea Pharmaceutica AG (BSLN) stock does not pay dividends to its shareholders.
What is the beta indicator for Basilea Pharmaceutica AG?
Basilea Pharmaceutica AG (BSLN) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.